Cargando…

Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy

BACKGROUND: Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) differ in histopathology and prognosis. Although transendocardial delivery of mesenchymal stem cells is safe and provides cardiovascular benefits in both, a comparison of mesenchymal stem cell efficacy in ICM versus DCM has n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tompkins, Bryon A., Rieger, Angela C., Florea, Victoria, Banerjee, Monisha N., Natsumeda, Makoto, Nigh, Evan D., Landin, Ana Marie, Rodriguez, Gianna M., Hatzistergos, Konstantinos E., Schulman, Ivonne Hernandez, Hare, Joshua M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064862/ https://www.ncbi.nlm.nih.gov/pubmed/30005555 http://dx.doi.org/10.1161/JAHA.117.008460

Ejemplares similares

Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
por: Rieger, Angela C., et al.
Publicado: (2019)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
por: Li, Xinyi, et al.
Publicado: (2023)

Ivabradine Improves Heart Rate Variability in Patients with Nonischemic Dilated Cardiomyopathy
por: Kurtoglu, Ertugrul, et al.
Publicado: (2014)

Distinct Circulating Expression Profiles of Long Noncoding RNAs in Heart Failure Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
por: Lin, Fang, et al.
Publicado: (2019)

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
por: Rieger, Angela C, et al.
Publicado: (2022)

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
por: Huang, Guangyong, et al.
Publicado: (2021)

Therapeutic Role of Mobilized Bone Marrow Cells in Children with Nonischemic Dilated Cardiomyopathy
por: Habeeb, Nevin M., et al.
Publicado: (2012)

Relationship between malnutrition and coronary microvascular dysfunction in patients with nonischemic dilated cardiomyopathy
por: KUL, Şeref, et al.
Publicado: (2020)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Biventricular thrombi of nonischemic cardiomyopathy
por: Adnan, Mohammed Muqeet, et al.
Publicado: (2014)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Sibutramine-Induced Nonischemic Cardiomyopathy
por: Shah, Meet S, et al.
Publicado: (2022)

Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
por: Romuk, Ewa, et al.
Publicado: (2019)

Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy
por: Li, Jiangtao, et al.
Publicado: (2023)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
por: Mansur, Antonio de Padua, et al.
Publicado: (2023)

Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy
por: Cojan-Minzat, Bianca Olivia, et al.
Publicado: (2020)

Temporal Changes in Beat‐to‐Beat Variability of Repolarization Predict Imminent Nonsustained Ventricular Tachycardia in Patients With Ischemic and Nonischemic Dilated Cardiomyopathy
por: Amoni, Matthew, et al.
Publicado: (2022)

Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)

CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy
por: Frljak, Sabina, et al.
Publicado: (2018)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
por: Kusano, Kengo
Publicado: (2018)

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials
por: Tripathi, Avnish, et al.
Publicado: (2021)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
por: Domae, Keitaro, et al.
Publicado: (2021)

Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)

Profile of nonischemic dilated cardiomyopathy patients with long-term survival ≥10 years on medical therapy alone
por: Monga, Inderjeet S., et al.
Publicado: (2022)

Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
por: Cadour, Farah, et al.
Publicado: (2023)

T1 Map-Based Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Nonischemic Dilated Cardiomyopathy
por: Chang, Suyon, et al.
Publicado: (2023)

The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
por: Okubo, Kenji, et al.
Publicado: (2018)

Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
por: Oladiran, Oreoluwa, et al.
Publicado: (2018)

Antifailure Therapy Including Spironolactone Improves Left Ventricular Energy Supply‐Demand Relations in Nonischemic Dilated Cardiomyopathy
por: Bell, Susan P., et al.
Publicado: (2014)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
por: Kim, Hyue-Mee, et al.
Publicado: (2021)

Role of Myocardial Perfusion Study in Differentiating Ischemic versus Nonischemic Cardiomyopathy Using Quantitative Parameters
por: Singh, Preeti, et al.
Publicado: (2018)

Meta‐analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy
por: Basu‐Ray, Indranill, et al.
Publicado: (2020)

Cardiomyocyte Regeneration in the mdx Mouse Model of Nonischemic Cardiomyopathy
por: Richardson, Gavin David, et al.
Publicado: (2015)

Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy
por: Pi, Shufang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kpifdbjhh30qvtbnl5t0gdh2v0